Inv€$table CEO Pitch Series: Emma Sceats, CEO of 28 North Discovery

Straight from the Inv€$table CEO Pitch Breakfast hosted by K&L Gates on Tuesday 24th May, we sat down with Emma Sceats, CEO of 28 North Discovery,to find out more about theirdrug discovery enabled by a unique and proven human organ-on-a-chip platform and alsowhy the CN Bio Innovations spin-out is such an investable opportunity.

Watch the exclusive interview with Emma Sceats

More exclusive video interviews and pitches visit here

Interested in an invitation to attend our future Inv€$tables or looking for investment partners to connect with? Register your interest here

Inv€$tables are a unique series of breakfast forums where life science companies pitch, profile and connect with capital and partners. 8 high calibre company CEO’s are selected to deliver 15 minute pitches to an audience of active, qualified investors and Pharma. CEOs are also afforded 15 minute profiling interviews followed by a 40 minute speed networking session and curated 1-2-1s.

Company Executives will have their video pitch, interview and an accompanying corporate profile released onto the Biotech and Money online portal post event. All this from a commitment of just 3 hours.

The June event takes place from 8-11am on 28th June at the Business Design Centre, Angel, London.

Author Blog
Written By

Add Your Response